-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
NeuroBo Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q3 2024.
- NeuroBo Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $5K, a 400% increase year-over-year.
- NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2023 was $6K, a 70% decline from 2022.
- NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2022 was $20K, a 58.3% decline from 2021.
- NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2021 was $48K, a 4.35% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)